insitro and UK’s INSIGHT at Moorfields Eye Hospital Announce Collaboration to Expand Research Efforts in Neurodegeneration and Related Conditions
The world’s largest bioresource of eye images offers window into human health and serves as basis of a new AI foundation model to boost drug discovery SOUTH SAN... Read more.
BioClec Launches With Backing From Sofinnova Partners to Pioneer Breakthrough Alzheimer’s Therapies
Co-founded by Dr. Marco Colonna, a global expert in neuroimmunology and Alzheimer’s research Led by CEO Gabriella Camboni, an eminent serial entrepreneur with... Read more.
Sofinnova Partners and Gustave Roussy launch first biotech company through Strategic Partnership
Signadori Bio, a novel cell therapy platform, emerges from collaboration with scientific founders Dr. Jean-Luc Perfettini and Professor Nathalie Chaput PARIS–(BUSINESS... Read more.
Forth Tx Launches With Backing From Sofinnova Partners to Revolutionize Fibrosis Treatments
Cutting-edge research from Professor Neil Henderson at the University of Edinburgh Led by CEO Alex Leech, Partner at Sofinnova Partners Created through Sofinnova’s... Read more.
Industry 4.0 Gaining Momentum in Europe
Under increasing pressure to reduce costs and a gain competitive edge, manufacturers are looking to providers to help them adopt intelligent systems, ISG Provider... Read more.
Mirantis and Gcore Partner to Tackle AI Infrastructure Challenges
SAN JOSE, Calif.–(BUSINESS WIRE)–#AIWorkloads—NVIDIA GTC – Mirantis, a leader in open-source cloud infrastructure and platform engineering, and... Read more.
Sygnia Appoints Technology Visionary Avi Golan as New CEO
Avi to spearhead cybersecurity innovation and expand Sygnia’s IR, Cyber Readiness and MDR leadership. TEL-AVIV, Israel & NEW YORK–(BUSINESS WIRE)–Sygnia,... Read more.
Sofinnova Partners Exceeds Target With €165M Biotech Acceleration Fund, Europe’s Largest, With Strong Pharma Support
Biovelocita II attracts robust support from leading pharmaceutical companies, including Amgen, Bristol Myers Squibb, and Pfizer Ventures The fund has already screened... Read more.
Global Trust in Digital Services Declines, Finds Thales
Thales 2025 Digital Trust Index reveals most industries experienced a decline in consumer trust compared to last year Privacy fears are becoming a major factor in... Read more.
ATLAS Welcomes Strengthened Commitment to Increased Shareholder Returns from SES Board
ATLAS supports the decision to modernize Board ATLAS welcomes SES’s strengthened commitment to increased shareholder returns and capital discipline ATLAS will... Read more.